Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Enters Into New $1B Revolving Credit Facility

NEW YORK (GenomeWeb) – Danaher last week entered into a new $1.0 billion 364-day revolving credit facility, the firm disclosed after the close of the market on Monday.

In a document filed with the US Securities and Exchange Commission, the company said that it entered into the facility with Bank of America, as the administrative agent, and a syndicate of lenders.

The credit facility expires on March 22, 2019. Danaher may elect to convert any loans outstanding on the schedule termination date into loans that are due and payable one year following the scheduled termination date. If it does so, it will pay a fee of .75 percent of the principal amount of the loans then outstanding.

Danaher said it intends to use the credit facility to expand its US and European commercial paper programs and for corporate purposes, and to fund a portion of its planned purchase of Integrated DNA Technologies.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.